

High-Risk Beta
This platform is experimental. Smart contracts are unaudited. Use at your own risk.
Healthy middle-aged people offered Alzheimer’s drug in world-first trial The Telegraph
Friday, 4 September 2026
Connect your wallet to join the discussion.
No comments yet. Be the first to share your take.